• About us
• Contact

Advertisement

Organisation › Details

Virion Biotherapeutics Ltd.

Founded in 2017, VirionHealth is developing a new class of biological antivirals to create improved therapeutics for respiratory viral infections. The company is focused on prevention and treatment of influenza and respiratory syncytial virus (RSV). *

 

	Start	2018-09-12 renamed
	Industry	virostatic agent
	Industry 2	drug development
	Person	King, Vanessa (Virion Biotherapeutics 201809– CEO before Luc Therapeutics + deCode Genetics + Tiaki Therapeutics)
	Person 2	Thompson, Nicola (Nicki) (Amphista Therapeutics 201906– CEO before Nanna Therapeutics + VirionHealth + Phico Tx)
	Region	London, Greater London
	Country	United Kingdom (GB)
	City	n. a. London
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: VirionHealth Ltd.. (10/12/17). "Press Release: VirionHealth Raises Series A Funding from Abingworth".
		Record changed: 2023-07-10

Advertisement

More documents for Virion Biotherapeutics Ltd.

• [1] Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London....
• [2] Virion Biotherapeutics Ltd.. (11/14/18). "Press Release: Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections". London....
• [3] Virion Biotherapeutics Ltd.. (9/17/18). "Press Release: Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO". London....
• [4] VirionHealth Ltd.. (10/12/17). "Press Release: VirionHealth Raises Series A Funding from Abingworth"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.